Kestine (Ebastine)

Ebastine selectively blocks peripheral H1 histamine receptors, preventing histamine from binding and triggering the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation. By antagonizing these receptors without readily crossing the blood‑brain barrier, ebastine provides effective control of allergy symptoms while minimizing central nervous system sedation commonly seen with first‑generation antihistamines.

The specific dose of Kestine is determined by the prescribing clinician. In clinical practice, adults are often started on a once‑daily dose, but the exact amount, frequency, and duration depend on the patient’s age, severity of symptoms, renal or hepatic function, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for ebastine during pregnancy and lactation are limited. The drug is generally classified as a precautionary agent, meaning it should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider before starting Kestine.

To request Kestine, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials to verify eligibility. After verification, the sales team provides pricing, availability, shipping details—including any temperature requirements—and assists with import documentation.

Compared with first‑generation antihistamines such as diphenhydramine, ebastine (Kestine) offers similar efficacy for allergic symptoms but with a lower incidence of sedation and anticholinergic effects because it does not readily cross the blood‑brain barrier. Relative to other second‑generation agents like cetirizine, ebastine has a comparable safety profile, though individual response and drug‑interaction potential may differ, making clinician selection based on patient characteristics important.

Kestine tablets should be stored at ambient temperature below 25 °C, protected from moisture and direct sunlight. Keep the medication in its original packaging until use, and ensure the container is tightly closed after each access. Do not store in bathrooms or near heat sources, and discard any tablets that appear discolored or damaged.

Kestine is taken orally, usually with a glass of water. It can be taken with or without food, although taking it with a meal may reduce occasional stomach discomfort. The tablet should be swallowed whole and not split, crushed, or chewed unless specifically instructed by a healthcare professional.

While generally well tolerated, Kestine may rarely cause serious adverse events. Patients should be alert for signs of severe skin reactions such as rash, blistering, or peeling, which could indicate Stevens‑Johnson syndrome. Cardiac irregularities, significant liver enzyme elevations, or anaphylactic reactions require immediate medical attention. Any unexpected or severe symptoms should prompt discontinuation and prompt evaluation by a physician.

Kestine is contraindicated in individuals with known hypersensitivity to ebastine or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, as exposure may be increased. Pregnant or nursing women should only use it if clearly indicated by a healthcare professional. Children under the approved age limit should not receive the medication without specific pediatric dosing guidance.